3-Fluorophenmetrazine
3-Fluorophenmetrazine (3-FPM) is a stimulant of the phenylmorpholine class that produces classical stimulant effects when administered. It is a derivative of phenmetrazine, a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s and 1960s.
History[edit | edit source]
3-Fluorophenmetrazine was first synthesized in the 1970s as part of a series of phenmetrazine analogs, but its activity was not reported until 2014. It was initially developed as a potential medication for obesity, but was never marketed.
Pharmacology[edit | edit source]
3-Fluorophenmetrazine acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), increasing levels of these neurotransmitters in the brain. This leads to increased alertness, focus, and euphoria. The exact mechanism of action is not fully understood, but it is believed to involve the inhibition of monoamine reuptake.
Effects[edit | edit source]
The effects of 3-Fluorophenmetrazine can vary greatly depending on the dose, individual physiology, and method of administration. Common effects include stimulation, increased focus, euphoria, and increased sociability. At higher doses, it can cause anxiety, paranoia, and hallucinations.
Legal Status[edit | edit source]
The legal status of 3-Fluorophenmetrazine varies by country. In some countries, it is a controlled substance, while in others it is legal to possess for personal use. It is important to check local laws before purchasing or using this substance.
Health Risks[edit | edit source]
As with all stimulants, 3-Fluorophenmetrazine carries a risk of addiction and physical dependence. It can also cause a range of negative health effects, including increased heart rate, high blood pressure, and potential damage to the cardiovascular system. Long-term use can lead to mental health issues such as depression and anxiety.
See Also[edit | edit source]
This stimulant-related article is a stub. You can help WikiMD by expanding it.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
